Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Colson

Showing results (391-400 of 402) with videos related to

Pageof 41
Sort By:
Frontiers in Microbiology|February 24, 2022
Analysis of SARS-CoV-2 Variants From 24,181 Patients Exemplifies the Role of Globalization and Zoonosis in PandemicsPhilippe Colson, Pierre-Edouard Fournier, Hervé Chaudet, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Isabelle Cohen-Codar, Martin S King, et al.
Nature Communications|February 13, 2025
Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemicChenkai Zhao, Tiantian Zhang, Ling Guo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 26, 2024
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024Alice Moisan, Hadrien Regue, Yannis Rahou, et al.
Scientific Reports|October 27, 2020
Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strainsOusmane Oumou Diallo, Sophie Alexandra Baron, Gregory Dubourg, et al.
Travel Medicine and Infectious Disease|April 15, 2020
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational studyPhilippe Gautret, Jean-Christophe Lagier, Philippe Parola, et al.
Journal of Medical Virology|October 27, 2009
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapyFlorence Legrand-Abravanel, Philippe Colson, Hélène Leguillou-Guillemette, et al.
Travel Medicine and Infectious Disease|May 11, 2020
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, FranceMatthieu Million, Jean-Christophe Lagier, Philippe Gautret, et al.
Reviews in Cardiovascular Medicine|September 26, 2021
Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatientsMatthieu Million, Jean-Christophe Lagier, Hervé Tissot-Dupont, et al.
Journal of Clinical Microbiology|February 22, 2013
Multicenter quality control of hepatitis C virus protease inhibitor resistance genotypingSophie Vallet, Sylvie Larrat, Syria Laperche, et al.
Pageof 41

Showing results (391-400 of 402) with videos related to

Sort By:
Pageof 41
Frontiers in Microbiology|February 24, 2022
Analysis of SARS-CoV-2 Variants From 24,181 Patients Exemplifies the Role of Globalization and Zoonosis in PandemicsPhilippe Colson, Pierre-Edouard Fournier, Hervé Chaudet, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Isabelle Cohen-Codar, Martin S King, et al.
Nature Communications|February 13, 2025
Characterising the asynchronous resurgence of common respiratory viruses following the COVID-19 pandemicChenkai Zhao, Tiantian Zhang, Ling Guo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 26, 2024
Performance of whole genome sequencing for respiratory syncytial virus: insights from the first external quality assessment, France, 2024Alice Moisan, Hadrien Regue, Yannis Rahou, et al.
Scientific Reports|October 27, 2020
Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strainsOusmane Oumou Diallo, Sophie Alexandra Baron, Gregory Dubourg, et al.
Travel Medicine and Infectious Disease|April 15, 2020
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational studyPhilippe Gautret, Jean-Christophe Lagier, Philippe Parola, et al.
Journal of Medical Virology|October 27, 2009
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapyFlorence Legrand-Abravanel, Philippe Colson, Hélène Leguillou-Guillemette, et al.
Travel Medicine and Infectious Disease|May 11, 2020
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, FranceMatthieu Million, Jean-Christophe Lagier, Philippe Gautret, et al.
Reviews in Cardiovascular Medicine|September 26, 2021
Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatientsMatthieu Million, Jean-Christophe Lagier, Hervé Tissot-Dupont, et al.
Journal of Clinical Microbiology|February 22, 2013
Multicenter quality control of hepatitis C virus protease inhibitor resistance genotypingSophie Vallet, Sylvie Larrat, Syria Laperche, et al.
Pageof 41